Oblique Therapeutics


Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Headquarters

Göteborg, Sweden

Employees

1-10

Links


Org chart

Collapse
Marie Scherlund
Chief Operating Officer
Lotta Ostler
VP Legal & HR

Board & advisors

Camilla Svensson
Board Member
Stefan Ståhl
Board Member
Lars Molinder
Board Member
Rolf Karlsten
Clinical Pain Advisor
Elias Arnér
Preclinical R&D Advisor